Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
Cognitive dysfunction
Dementia
Early detection
Mild cognitive impairment
Neuropsychology
Parkinson’s disease
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
26
05
2020
accepted:
12
08
2020
revised:
10
08
2020
pubmed:
18
8
2020
medline:
22
6
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Cognitive impairment is prevalent among individuals with Parkinson's disease (PD). Effort has been made to identify individuals at risk for cognitive decline and dementia. Objectively-defined subtle cognitive decline (Obj-SCD) is a novel classification that may identify individuals at risk for cognitive decline prior to a diagnosis of mild cognitive impairment (MCI). We examined the utility of Obj-SCD criteria to predict future cognitive decline and difficulties with activities of daily living (ADLs) among individuals with PD. The sample included 483 individuals newly diagnosed with PD. Participants were followed for a five-year span with yearly visits where they completed neuropsychological tests. Participants were categorized as cognitively normal (CN), the newly proposed Obj-SCD, PD-MCI or Parkinson's disease dementia (PDD). Analyses determined if utilization of Obj-SCD criteria predicted subsequent cognitive impairment and difficulties with ADLs. At baseline, 372 (77%) participants were classified as CN, 40 (8.3%) classified as Obj-SCD, and 71 (14.7%) classified as PD-MCI. Analyses revealed that relative to the CN group, participants classified as Obj-SCD at baseline, were more likely to develop PD-MCI or PDD within 5 years (odds ratio 2.413; 95% confidence interval 1.215-4.792). Furthermore, the Obj-SCD represented an intermediate level of impairment, relative to the CN and PD-MCI groups, on an independent measure of cognition (Montreal Cognitive Assessment) and ADL. Findings provide evidence that Obj-SCD criteria can identify individuals at risk for cognitive decline and impairments in ADL. Obj-SCD criteria may identify individuals at risk for cognitive impairment who are not detected by PD-MCI criteria.
Identifiants
pubmed: 32804281
doi: 10.1007/s00415-020-10163-4
pii: 10.1007/s00415-020-10163-4
pmc: PMC7855683
mid: NIHMS1621152
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-345Subventions
Organisme : NIGMS NIH HHS
ID : T34 GM136467
Pays : United States
Organisme : U.S. Department of Veterans Affairs
ID : 1IK2CX001865
Organisme : NIGMS NIH HHS
ID : T34 GM083883
Pays : United States
Organisme : CSRD VA
ID : IK2 CX001865
Pays : United States
Organisme : NIH HHS
ID : T34GM083883
Pays : United States
Références
Papagno C, Trojano L (2018) Cognitive and behavioral disorders in Parkinson’s disease: an update. I: cognitive impairments. Neurol Sci 39(2):215–223. https://doi.org/10.1007/s10072-017-3154-8
doi: 10.1007/s10072-017-3154-8
pubmed: 29043468
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Santangelo G (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75(12):1062–1069. https://doi.org/10.1212/WNL.0b013e3181f39d0e
doi: 10.1212/WNL.0b013e3181f39d0e
pubmed: 20855849
pmcid: 2942065
Wen MC, Chan LL, Tan LC, Tan EK (2017) Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity? Transl Neurodegener 6(1):24. https://doi.org/10.1186/s40035-017-0094-4
doi: 10.1186/s40035-017-0094-4
pubmed: 28919975
pmcid: 5596909
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844. https://doi.org/10.1002/mds.21956
doi: 10.1002/mds.21956
pubmed: 18307261
Fernandez HH, Crucian GP, Okun MS, Price CC, Bowers D (2005) Mild cognitive impairment in Parkinson’s disease: the challenge and the promise. Neuropsychiatr Dis Treat 1(1):37–50. https://doi.org/10.2147/nedt.1.1.37.52295
doi: 10.2147/nedt.1.1.37.52295
pubmed: 18568128
pmcid: 2426819
Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Weintraub D (2011) MDS Task Force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI. Mov Disord 26(10):1814–1824. https://doi.org/10.1002/mds.23823
doi: 10.1002/mds.23823
pubmed: 21661055
pmcid: 3181006
Roheger M, Kalbe E, Liepelt-Scarfone I (2018) Progression of cognitive decline in Parkinson’s disease. J Parkinsons Dis 8(2):183–193. https://doi.org/10.3233/JPD-181306
doi: 10.3233/JPD-181306
pubmed: 29914040
pmcid: 6004891
Bäckström D, Granåsen G, Domellöf ME, Linder J, Mo SJ, Riklund K, Forsgren L (2018) Early predictors of mortality in parkinsonism and Parkinson disease: a population-based study. Neurology 91(22):e2045–e2056. https://doi.org/10.1212/WNL.0000000000006576
doi: 10.1212/WNL.0000000000006576
pubmed: 30381367
pmcid: 6282235
Jones JD, Mangal P, Lafo J, Okun MS, Bowers D (2016) Mood differences among Parkinson’s disease patients with mild cognitive impairment. J Neuropsychiatry Clin Neurosci 28(3):211–216. https://doi.org/10.1016/j.parkreldis.2017.12.006
doi: 10.1016/j.parkreldis.2017.12.006
pubmed: 26792098
pmcid: 4956595
Jones JD, Kuhn TP, Szymkowicz SM (2018) Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: analysis of the PPMI cohort. Parkinsonism Relat Disord 47:3–7. https://doi.org/10.1016/j.parkreldis.2017.12.006
doi: 10.1016/j.parkreldis.2017.12.006
pubmed: 29233608
Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP (2018) Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment. Mov Disord 33(4):503–510. https://doi.org/10.1002/mds.27323
doi: 10.1002/mds.27323
pubmed: 29488270
Galtier I, Nieto A, Lorenzo JN, Barroso J (2019) Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study. J Neurol 266(3):745–754. https://doi.org/10.1007/s00415-019-09197-0
doi: 10.1007/s00415-019-09197-0
pubmed: 30635723
Hong JY, Sunwoo MK, Chung SJ, Ham JH, Lee JE, Sohn YH, Lee PH (2014) Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson’s disease. Neurobiol Aging 35(7):1739–1743. https://doi.org/10.1016/j.neurobiolaging.2013.11.017
doi: 10.1016/j.neurobiolaging.2013.11.017
pubmed: 24507441
Orfei MD, Assogna F, Pellicano C, Pontieri FE, Caltagirone C, Pierantozzi M, Spalletta G (2018) Anosognosia for cognitive and behavioral symptoms in Parkinson’s disease with mild dementia and mild cognitive impairment: frequency and neuropsychological/neuropsychiatric correlates. Parkinsonism Relat Disord 54:62–67. https://doi.org/10.1016/j.parkreldis.2018.04.015
doi: 10.1016/j.parkreldis.2018.04.015
pubmed: 29709507
Mitchell AJ (2008) The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta-analysis. Int J Geriatr Psychiatry J Psychiatry Late Life Allied Sci 23(11):1191–1202. https://doi.org/10.1002/gps.2053
doi: 10.1002/gps.2053
Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW (2015) Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease. J Alzheimers Dis 47(1):231–242. https://doi.org/10.3233/JAD-150128
doi: 10.3233/JAD-150128
pubmed: 26402771
pmcid: 4634634
Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative (2018) Using neuropsychological process scores to identify subtle cognitive decline and predict progression to mild cognitive impairment. J Alzheimers Dis 64(1):195–204. https://doi.org/10.3233/JAD-180229
doi: 10.3233/JAD-180229
pubmed: 29865077
pmcid: 7263028
Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, Bondi MW (2018) Word-list intrusion errors predict progression to mild cognitive impairment. Neuropsychology 32(2):235. https://doi.org/10.1037/neu0000413
doi: 10.1037/neu0000413
pubmed: 29528684
pmcid: 5851458
Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Wong CG, Cooper S, Alzheimer’s Disease Neuroimaging Initiative (2020) Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology 94(4):e397–e406. https://doi.org/10.1212/WNL.0000000000008838
doi: 10.1212/WNL.0000000000008838
pubmed: 31888974
Jones JD, Burroughs M, Apodaca M, Bunch J (2019) Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson’s disease. Neuropsychology. https://doi.org/10.1037/neu0000577
doi: 10.1037/neu0000577
pubmed: 31343240
pmcid: 6823115
Brønnick K, Alves G, Aarsland D, Tysnes O, Larsen J (2011) Verbal memory in drug-naive, newly diagnosed Parkinson’s disease. The retrieval deficit hypothesis revisited. Neuropsychology 25(1):114–124. https://doi.org/10.1037/a0020857
doi: 10.1037/a0020857
pubmed: 20954781
Higginson C, Wheelock V, Carroll K, Sigvardt K (2005) Recognition memory in Parkinson’s disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol 27(4):516–528. https://doi.org/10.1080/13803390490515469
doi: 10.1080/13803390490515469
pubmed: 15962695
Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Clark CM (2011) Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 68(12):1562–1568. https://doi.org/10.1001/archneurol.2011.725
doi: 10.1001/archneurol.2011.725
pubmed: 22159053
pmcid: 3290902
Anderson AE, Jones JD, Thaler NS, Kuhn TP, Singer EJ, Hinkin CH (2018) Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV. Neuropsychology 32(8):966. https://doi.org/10.1037/neu0000482
doi: 10.1037/neu0000482
pubmed: 30211610
pmcid: 6234088
Bangen KJ, Weigand AJ, Thomas KR, Delano-Wood L, Clark LR, Eppig J, Bondi MW (2019) Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. Neuropsychology 33(5):599. https://doi.org/10.1037/neu0000532
doi: 10.1037/neu0000532
pubmed: 30896235
pmcid: 7380511
Wyman-Chick KA, Martin PK, Weintraub D, Sperling SA, Erickson LO, Manning CA, Barrett MJ (2018) Selection of normative group affects rates of mild cognitive impairment in Parkinson’s disease. Mov Disord 33(5):839–843. https://doi.org/10.1002/mds.27335
doi: 10.1002/mds.27335
pubmed: 29442392
pmcid: 5992013
Zanchi D, Giannakopoulos P, Borgwardt S, Rodriguez C, Haller S (2017) Hippocampal and amygdala gray matter loss in elderly controls with subtle cognitive decline. Front Aging Neurosci 9:50. https://doi.org/10.3389/fnagi.2017.00050
doi: 10.3389/fnagi.2017.00050
pubmed: 28326035
pmcid: 5340094
Jones JD, Kurniadi NE, Kuhn TP, Szymkowicz SM, Bunch J, Rahmani E (2019) Depressive symptoms precede cognitive impairment in de novo Parkinson’s disease patients: analysis of the PPMI cohort. Neuropsychology. https://doi.org/10.1037/neu0000583
doi: 10.1037/neu0000583
pubmed: 31343240
pmcid: 6823115